Cite

HARVARD Citation

    van der Sangen, N. et al. (2022). P2Y12-inhibitor monotherapy after coronary stenting: are all P2Y12-inhibitors equal?. Expert review of cardiovascular therapy. pp. 637-645. [Online]. 
  
Back to record